6 results match your criteria: "Xi'an International Medical Centre Hospital[Affiliation]"
Lab Chip
October 2024
School of Microelectronics, Hefei University of Technology, Hefei, 230601, China.
J Coll Physicians Surg Pak
June 2024
Department of Medical Oncology, Xi'an International Medical Centre Hospital, Xi'an, China.
Objective: To evaluate the efficacy and safety of eribulin plus anti-angiogenic medicine in metastatic breast cancer (MBC), and explore the potential biomarkers.
Study Design: Observational study. Place and Duration of the Study: Department of Medical Oncology, Xi'an International Medical Centre Hospital, Xi'an, China, from May 2022 to 2023.
Heliyon
January 2024
Department of Thoracic Surgery, The Second Affiliated Hospital of the Air Force Medical University, Xi'an, Shaanxi Province, China.
Background: Rising rates of lung cancer screening have contributed to an increase in pulmonary nodule diagnosis rates. Studies have shown that psychosocial factors and hormones have an impact on the development of the oncological diseases. Therefore, we conducted this study to explore the potential relationship between pulmonary nodules pathology and patient personality traits and hormone levels.
View Article and Find Full Text PDFJ Int Med Res
March 2023
Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Cervical cancer is one of the most common malignant tumours of female reproductive system. Concurrent chemoradiotherapy is the standard treatment for locally advanced cervical cancer and brachytherapy is an irreplaceable part of cervical cancer radiotherapy. However, bilateral cervical cancer in a complete septate is extremely rare.
View Article and Find Full Text PDFMol Omics
February 2023
Clinical Experimental Centre, Xi'an International Medical Centre Hospital, 777, Xitai Road, Hightech-zone, Xi'an, Shaanxi 710100, P. R. China.
The atrial natriuretic peptide (ANP) and the brain natriuretic peptide (BNP) are critical biological makers and regulators of cardiac functions. Our previous results show that NPRA (natriuretic peptide receptor A)-deficient mice have distinct metabolic patterns and expression profiles compared with the control. Still, the molecular mechanism that could account for this observation remains to be elucidated.
View Article and Find Full Text PDFMol Med Rep
January 2021
Clinical Experimental Centre, Xi'an International Medical Centre Hospital, Xi'an, Shaanxi 710100, P.R. China.
Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are important biological markers and regulators of cardiac function. The natriuretic peptide receptor A (NPRA), also known as NPR1 or guanylyl cyclase A, binds ANP and BNP to initiate transmembrane signal transduction by elevating the intracellular levels of cyclic guanosine monophosphate. However, the effects and mechanisms downstream of NPRA are largely unknown.
View Article and Find Full Text PDF